Acadia Healthcare Provides Business Outlook Ahead of Investor Day
Acadia Healthcare Company (NASDAQ: ACHC) hosted its first Investor Day on December 7, 2022, in New York City. The management team shared insights into Acadia's behavioral healthcare services, growth strategy, and financial outlook. The company reaffirmed its 2022 guidance and provided initial guidance for 2023, estimating revenue between
- Reaffirmed 2022 revenue guidance of $2.58 to $2.60 billion.
- Provided optimistic 2023 revenue guidance of $2.79 to $2.86 billion.
- Projected Adjusted EBITDA for 2023 between $630 million and $680 million.
- None.
During the event, members of Acadia’s management team will provide an overview of the Company’s behavioral healthcare services and review Acadia’s growth strategy and financial outlook. The Company will affirm its previously issued guidance for 2022 and provide initial guidance for 2023, as follows:
|
2022 |
2023 |
||||
Revenue |
|
|
||||
Adjusted EBITDA (1) |
|
|
||||
Adjusted earnings per diluted share (1) |
|
|
||||
(1) Excluding income from provider relief fund |
“We are excited to provide a comprehensive overview of our operations and to review our growth strategy with our investors,” said
The investor day presentation will be available to investors via a live webcast. A link to the webcast is posted on the investor relations section of the Company’s website at https://www.acadiahealthcare.com/investors/event-calendar, and a replay will be available for 90 days.
About
Acadia is a leading provider of behavioral healthcare services across
Non-GAAP Financial Information
The Company is not able to provide a reconciliation of projected Adjusted EBITDA and adjusted earnings per diluted share, where provided and whether including or excluding income from provider relief fund, to expected results due to the unknown effect, timing and potential significance of transaction related expenses and the tax effect of such expenses.
Forward-Looking Information
This press release contains forward-looking statements. Generally, words such as “may,” “will,” “should,” “could,” “anticipate,” “expect,” “intend,” “estimate,” “plan,” “continue,” and “believe” or the negative of or other variation on these and other similar expressions identify forward-looking statements. These forward-looking statements are made only as of the date of this press release. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements are based on current expectations and involve risks and uncertainties and our future results could differ significantly from those expressed or implied by our forward-looking statements. Factors that may cause actual results to differ materially include, without limitation, (i) the impact of general economic and employment conditions, including increased labor, construction and other costs; (ii) the impact of the COVID-19 pandemic on our inpatient and outpatient admissions and volumes, or disruptions caused by other pandemics, epidemics or outbreaks of infectious diseases; (iii) potential difficulties in successfully integrating the operations of acquired facilities or realizing the expected benefits and synergies of our facility expansions, acquisitions, joint ventures and de novo transactions; (iv) Acadia’s ability to add beds, expand services, enhance marketing programs and improve efficiencies at its facilities; (v) potential reductions in payments received by Acadia from government and third-party payors; (vi) the occurrence of patient incidents, governmental investigations, litigation and adverse regulatory actions, which could adversely affect the price of our common stock and result in substantial payments and incremental regulatory burdens; (vii) the risk that Acadia may not generate sufficient cash from operations to service its debt and meet its working capital and capital expenditure requirements; (viii) potential disruptions to our information technology systems or a cybersecurity incident; and (ix) potential operating difficulties, changes in client preferences, competition and general industry conditions that may prevent Acadia from realizing the expected benefits of its business strategies. These factors and others are more fully described in Acadia’s periodic reports and other filings with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20221207005301/en/
Vice President, Investor Relations
InvestorRelations@acadiahealthcare.com
(615) 861-6000
Source:
FAQ
What is Acadia Healthcare's revenue guidance for 2023?
When did Acadia Healthcare hold its Investor Day?
What are the projected Adjusted EBITDA figures for Acadia Healthcare in 2023?